The two firms are expanding their partnership by introducing a new virtual clinical study which will attempt to discover improved diagnostics by observing 1000 participants affected by COVID-19.
Adaptive biotechnologies RSS
In an effort to create what it calls a "universal blood test" and thus enable better treatment and detection of disease, Microsoft has partnered with Seattle-based Adaptive Biotechnologies.
